baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UBS Knock-Out AMGN/ DE000UM2B9D9 /

2024-05-30 9:12:11 AM	Chg.-0.040	Bid9:12:11 AM	Ask9:12:11 AM	Underlying	Strike price	Expiration date	Option type
0.710EUR	-5.33%	0.710 Bid Size: 25,000	0.810 Ask Size: 25,000	Amgen Inc	376.8747 USD	2078-12-31	Put

TeleTrader 05-28 US markets turn to losses, Dow plunges 330 points

TeleTrader 05-28 Wall Street opens mostly higher as T+1 stock trading returns

GlobeNewswire 05-28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD

GlobeNewswire 05-27 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...

GlobeNewswire 05-23 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...

GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 05-22 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...

GlobeNewswire 05-21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update

GlobeNewswire 05-21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...

GlobeNewswire 05-21 COUR Pharmaceuticals Appoints Paul M. Peloso, MD, as Chief Medical Officer

TeleTrader 05-16 FDA approves Amgen's small cell lung cancer drug

GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants

GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 05-14 Accumulus Synergy Sponsors Revolutionary Healthcare Data Standard, Advancing Towards Global Dossier

GlobeNewswire 05-14 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...

GlobeNewswire 05-13 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan

GlobeNewswire 05-09 argenx Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...

GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

TeleTrader 05-08 US closes flat to higher with more earnings on the horizon

GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

TeleTrader 05-03 US closes higher after softer-than-expected jobs print

TeleTrader 05-03 Wall Street surges on open as jobs report sparks rate cut hopes

UBS Knock-Out AMGN/ DE000UM2B9D9 /

If you wish to receive reply to your feedback, please provide your email address.